Payment and Funding Mechanisms

Slides:



Advertisements
Similar presentations
Translating Evidence into Practice Danny Liew Melbourne EpiCentre Medical Unit 1.
Advertisements

Early stages of research programmes: pilot and feasibility studies From Scoping to Activity Rehabilitation Conference A Byrne.
Donald T. Simeon Caribbean Health Research Council
A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.
1 Are you sure your improvements are cost-effective? Edward Broughton, PhD, MPH, PT University Research Co. April 11, 2014
Introduction to Pharmacoeconomics
“Rational Pharmacology” and Health Economics By Alan Maynard.
Utilizing Evidence Based Practice in the Acute Care Clinical Setting Brenda P. Johnson, PhD, RN Department of Nursing Southeast Missouri State University.
Economic Analysis and Management Todd Wagner, PhD.
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. February 25, 2009.
Economic evaluation considers assessment of intervention effects in economic terms, which is often of greatest interest to fund allocators Intervention.
Alan M. Garber, M.D., Ph.D. Center for Primary Care and Outcomes Research Center for Health Policy Stanford University VA Palo Alto Health Care System.
The Panel on Cost-Effectiveness in Health and Medicine Marthe Gold City University of London 30 October, 2003.
The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older Dana P. Goldman, Federico Girosi et al. American Journal of Public Health November.
Agenda: Block Watch: Random Assignment, Outcomes, and indicators Issues in Impact and Random Assignment: Youth Transition Demonstration –Who is randomized?
Health Care Financing in Pakistan: Trends and Issues
Trends In Health Care Industry KNH 413. Difficult questions What is health insurance? What is health care versus health insurance? Is one or both a right.
Assessing cost-effectiveness – what is an ICER?- Incremental analysis
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
1 Cost-effectiveness of improving medical services in low-resource settings Edward Broughton, PhD, MPH, PT University Research Co. May 21, 2014
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
These slides were released by the speaker for internal use by Novartis.
PHAR 310: Pharmacoeconomics
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
Uses of Health Care Funds in the U.S. (2010) Source: Centers for Medicare and Medicaid Services [2012c]
Testing, Piloting and Evaluating RiskMAP Interventions Annette Stemhagen, DrPH, FISPE Vice President, Strategic Development Services.
Hypertension: Blood Pressure Measurement and the new NICE guideline Prof Richard McManus BHS Annual Meeting Cambridge 2011 NICE clinical guideline 127.
Basic Economic Analysis David Epstein, Centre for Health Economics, York.
Secondary Translation: Completing the process to Improving Health Daniel E. Ford, MD, MPH Vice Dean Johns Hopkins School of Medicine Introduction to Clinical.
This material was developed by Oregon Health & Science University, funded by the Department of Health and Human Services, Office of the National Coordinator.
Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
Evidence-Based Medicine Presentation [Insert your name here] [Insert your designation here] [Insert your institutional affiliation here] Department of.
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. September 14, 2011.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 23: Nov 17, 2008.
Chapter 8 Long-Term (Capital Investment) Decisions.
1 The Impact of Low Income Home Owners on the Volatility of Housing Markets Peter Westerheide ZEW European Real Estate Society Conference 2009 Stockholm.
Evidence-Based Medicine – Definitions and Applications 1 Component 2 / Unit 5 Health IT Workforce Curriculum Version 1.0 /Fall 2010.
EVIDENCE BASED PRACTICE BY MOHEB KHOUZAM MD. EVIDENCE BASED PRACTICE  1- TYPES OF STUDY DESIGNS  2- RECOMMENDATIONS.
Workpackage 2: Review and quantitative evaluation of the effectiveness of interventions University of Reading.
Cost-Effectiveness and Outcomes Research Setting value to what we do.
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
Research Design Evidence Based Medicine Concepts and Glossary.
BIOE 301 Lecture Sixteen. Review of Lectures What is the goal of cancer screening? Successful cancer screening examples? Can screening hurt more.
Research Methodology Group Members: April Tulloch Kerekia Walker Sashield Walker Daneik Wallace Juliann Wallace Nicole Wallace Lecturer: Dr. J. Lindo.
© University of South Wales Royal College of Speech and Language Therapists Outcomes Conference and Hub Launch Belfast, May 1, 2014 Running a tight ship:
Balancing revenues and costs for orphan drugs: a case study Aidan Hollis University of Calgary: Department of Economics and O’Brien Institute of Public.
IMPACT EVALUATION PBAF 526 Class 5, October 31, 2011.
Economics of Complementary and Integrative Medicine: Where Do We Go From Here? Patricia M. Herman, ND, PhD, RAND Corporation IM4US Boston August 8, 2014.
Advancing Health Economics, Services, Policy and Ethics Collecting Real World Evidence: HTA’s perspective Dr. Kelvin Chan, MD FRCPC MSc (Clin Epi) MSc.
A Focus on International Child Health and Child Well-being Supporting the Child Health Strategy through Improved Child Health Data and Intelligence ChiMat.
Significance or impacts of proposed research
Building an Evidence-Based Nursing Practice
Understanding Health Systems: The Organization of
What is the Optimal Rate of DES Use?
Cost effectiveness Analysis: Valuing Health; Valuing Research!
HEALTH ECONOMICS BASICS
Global burden of diseases
Present: Disease Past: Exposure
Financing Heath Care in Low Income Coutnries
Introduction to Evidence- Based Practice
Mechanical thrombectomy
Background & Objectives
Prior authorization and patient cost-sharing are least likely to be seen as effective in reducing unnecessary care. “How effective do you think each of.
Adapted from a presentation at the Rwanda First National Workshop on
BIOE 301 Lecture Sixteen.
Encouraging care coordination in FFS Medicare
EPIDEMIOLOGY AS A TOOL TO EVALUATE QUALITY OF CARE
PICO model for developing EBM questions
Presentation Developed for the Academy of Managed Care Pharmacy
Presentation transcript:

Payment and Funding Mechanisms October 10, 2000

A continuation of the previous discussion How is X paid for? by whom? with what associated incentives/disincentives? what difference did it make? Columbia University School of Nursing M6920, Spring 2000

Cost and outcomes efficacy effectiveness efficiency Columbia University School of Nursing M6920, Spring 2000

Efficacy Does the therapy work in well-controlled clinical trials Is this worth doing at all? Columbia University School of Nursing M6920, Spring 2000

Effectiveness Does the therapy work in routine care? Can it be carried out by ordinary practitioners? Usually a smaller benefit than demonstrated in efficacy study Columbia University School of Nursing M6920, Spring 2000

Efficiency Is the cost of doing the therapy worth the financial and other costs? Based on cost/effectiveness study Cost calculated per unit of health obtained year of survival hospitalization avoided Columbia University School of Nursing M6920, Spring 2000

Cost benefit studies done to compare net cost of interventions into different problems can also be identified as cost utility studies requires use of QALY or DALY for comparative purposes Columbia University School of Nursing M6920, Spring 2000

Major issues in cost benefit studies defining the scope of the question (all disease, all populations, geography) deciding perspective gold standard requires societal perspective Columbia University School of Nursing M6920, Spring 2000

More issues deciding the time interval for analysis filling in data blanks literature expert opinion Columbia University School of Nursing M6920, Spring 2000

Cassidy et al Policy change creates natural experiment in effect of paymen Existing claims data base Outcome measure: length of case Conclusion: decreased incidence Columbia University School of Nursing M6920, Spring 2000

Di Matteo Past studies: variation is due to GDP Pooled time-series cross section regression analysis Ratios by province over time Key factors real per capita income proportion over 65 real federal $$ transfer Columbia University School of Nursing M6920, Spring 2000

Di Matteo Design clarity? Data sources? Discussion? Columbia University School of Nursing M6920, Spring 2000

Broyles et al Risk adjustment is major challenge Model building research assumption that risks in population govern use/cost Comparison of two approaches reference case vs. adjusted Columbia University School of Nursing M6920, Spring 2000

Feder et al. Overview of knowledge What questions are raised? Columbia University School of Nursing M6920, Spring 2000